These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21685939)

  • 1. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.
    Girnita A; Zheng H; Grönberg A; Girnita L; Ståhle M
    Oncogene; 2012 Jan; 31(3):352-65. PubMed ID: 21685939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1.
    Dalle S; Imamura T; Rose DW; Worrall DS; Ugi S; Hupfeld CJ; Olefsky JM
    Mol Cell Biol; 2002 Sep; 22(17):6272-85. PubMed ID: 12167719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
    Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
    J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor.
    Zheng H; Worrall C; Shen H; Issad T; Seregard S; Girnita A; Girnita L
    Proc Natl Acad Sci U S A; 2012 May; 109(18):7055-60. PubMed ID: 22509025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma.
    Zheng H; Shen H; Oprea I; Worrall C; Stefanescu R; Girnita A; Girnita L
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20620-5. PubMed ID: 23188799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
    Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.
    Zhang Y; Moerkens M; Ramaiahgari S; de Bont H; Price L; Meerman J; van de Water B
    Breast Cancer Res; 2011 May; 13(3):R52. PubMed ID: 21595894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional antagonism of β-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes.
    Suleymanova N; Crudden C; Shibano T; Worrall C; Oprea I; Tica A; Calin GA; Girnita A; Girnita L
    Oncogene; 2017 Oct; 36(41):5734-5744. PubMed ID: 28581517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways.
    Wang H; Su X; Fang J; Xin X; Zhao X; Gaur U; Wen Q; Xu J; Little PJ; Zheng W
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.
    Yanagisawa T; Ishii M; Takahashi M; Fujishima K; Nishimura M
    Mol Biol Rep; 2020 Sep; 47(9):6841-6854. PubMed ID: 32886325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression.
    Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Vasilcanu D; Girnita A; Lefkowitz RJ; Larsson O
    J Biol Chem; 2007 Apr; 282(15):11329-38. PubMed ID: 17303558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.
    Girnita L; Worrall C; Takahashi S; Seregard S; Girnita A
    Cell Mol Life Sci; 2014 Jul; 71(13):2403-27. PubMed ID: 24276851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.
    Cao H; Dong W; Shen H; Xu J; Zhu L; Liu Q; Du J
    PLoS One; 2015; 10(8):e0135844. PubMed ID: 26287334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-Like Growth Factor-1 Contributes to Mucosal Repair by β-Arrestin2-Mediated Extracellular Signal-Related Kinase Signaling in Experimental Colitis.
    Chen T; Zheng F; Tao J; Tan S; Zeng L; Peng X; Wu B
    Am J Pathol; 2015 Sep; 185(9):2441-53. PubMed ID: 26362717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.
    Vasilcanu R; Vasilcanu D; Rosengren L; Natalishvili N; Sehat B; Yin S; Girnita A; Axelson M; Girnita L; Larsson O
    Oncogene; 2008 Mar; 27(11):1629-38. PubMed ID: 17828296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
    Li M; Chiu JF; Gagne J; Fukagawa NK
    J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The viral G protein-coupled receptor ORF74 unmasks phospholipase C signaling of the receptor tyrosine kinase IGF-1R.
    de Munnik SM; van der Lee R; Velders DM; van Offenbeek J; Smits-de Vries L; Leurs R; Smit MJ; Vischer HF
    Cell Signal; 2016 Jun; 28(6):595-605. PubMed ID: 26931381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Arrestin signal complex plays a critical role in adipose differentiation.
    Santos-Zas I; Lodeiro M; Gurriarán-Rodríguez U; Bouzo-Lorenzo M; Mosteiro CS; Casanueva FF; Casabiell X; Pazos Y; Camiña JP
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1281-92. PubMed ID: 23557604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.
    Niu XL; Li J; Hakim ZS; Rojas M; Runge MS; Madamanchi NR
    J Biol Chem; 2007 Jul; 282(27):19808-19. PubMed ID: 17500057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.